A capillary electrophoresis method to assay catalytic activity of botulinum neurotoxin serotypes: Implications for substrate specificity

Analytical Biochemistry

Volumn 366, Issue 2, 2007, Pages 207-217

  Purcell, Angela L ^a   Hoard Fruchey, Heidi M ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Botulinum neurotoxin; Capillary electrophoresis; Catalytic activity; Enzyme assay; Serotypes

Indexed keywords

CAPILLARY ELECTROPHORESIS; ENZYME ACTIVITY; PEPTIDES; SUBSTRATES;

BOTULINUM NEUROTOXINS; ENZYME ASSAYS; NEUROTRANSMITTER RELEASE; PEPTIDE SUBSTRATES; POTENTIAL INHIBITORS; POTENTIAL SUBSTRATE; SEROTYPES; SUBSTRATE SPECIFICITY;

CATALYST ACTIVITY;

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN E; BOTULINUM TOXIN F; BOTULINUM TOXIN G; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL WARFARE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME KINETICS; ENZYME SPECIFICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE;

EID: 34250219642     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.04.048     Document Type: Article

References (40)

1. Montecucco C., and Molgo J. Botulinal neurotoxins: Revival of an old killer. Curr. Opin. Pharmacol. 5 (2005) 274-279
2. Simpson L.L. Identification of the major steps in botulinum toxin action. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 167-193
3. Cherington M. Botulism: Update and review. Semin. Neurol. 24 (2004) 155-163
4. Middlebrook J.L., and Franz D.R. Botulinum toxins. In: Sidell F.R., Takafuji E.T., and Franz D.R. (Eds). Medical Aspects of Chemical and Biological Warfare Office of the Surgeon General at TMM Publications (1997), Borden Institute, Washington, DC 643-654
5. Arnon S.S., Schechter R., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Hauer J., Layton M., Lillibridge S., Osterholm M.T., O'Toole T., Parker G., Perl T.M., Russell P.K., Swerdlow D.L., and Tonat K. Botulinum toxin as a biological weapon: Medical and public health management. JAMA 285 (2001) 1059-1070
6. Schmidt J.J., Stafford R.G., and Millard C.B. High-throughput assays for botulinum neurotoxin proteolytic activity: Serotypes A, B, D, and F. Anal. Biochem. 296 (2001) 130-137
7. Li L., Binz T., Niemann H., and Singh B.R. Probing the mechanistic role of glutamate residue in the zinc-binding motif of type A botulinum neurotoxin light chain. Biochemistry 39 (2000) 2399-2405
8. Chen S., and Barbieri J.T. Unique substrate recognition by botulinum neurotoxins serotypes A and E. J. Biol. Chem. 281 (2006) 10906-10911
9. Baldwin M.R., Bradshaw M., Johnson E.A., and Barbieri J.T. The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability. Protein Expr. Purif. 37 (2004) 187-195
10. Schmidt J.J., and Stafford R.G. Botulinum neurotoxin serotype F: Identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity. Biochemistry 44 (2005) 4067-4073
11. Foran P., Shone C.C., and Dolly J.O. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments. Biochemistry 33 (1994) 15365-15374
12. Schmidt J.J., and Stafford R.G. A high-affinity competitive inhibitor of type A botulinum neurotoxin protease activity. FEBS Lett. 532 (2002) 423-426
13. m. Anal. Biochem. 219 (1994) 383-384
14. Rossetto O., Schiavo G., Montecucco C., Poulain B., Deloye F., Lozzi L., and Shone C.C. SNARE motif and neurotoxins. Nature 372 (1994) 415-416
15. Washbourne P., Pellizzari R., Baldini G., Wilson M.C., and Montecucco C. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis. FEBS Lett. 418 (1997) 1-5
16. Vaidyanathan V.V., Yoshino K., Jahnz M., Dorries C., Bade S., Nauenburg S., Niemann H., and Binz T. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: Domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage. J. Neurochem. 72 (1999) 327-337
17. Schmidt J.J., and Stafford R.G. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F. Appl. Environ. Microbiol. 69 (2003) 297-303
18. Breidenbach M.A., and Brunger A.T. Substrate recognition strategy for botulinum neurotoxin serotype A. Nature 432 (2004) 925-929
19. Blasi J., Chapman E.R., Yamasaki S., Binz T., Niemann H., and Jahn R. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J. 12 (1993) 4821-4828
20. Schiavo G., Shone C.C., Bennett M.K., Scheller R.H., and Montecucco C. Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J. Biol. Chem. 270 (1995) 10566-10570
21. Adler M., Shafer H.F., Manley H.A., Hackley Jr. B.E., Nicholson J.D., Keller J.E., and Goodnough M.C. A capillary electrophoresis technique for evaluating botulinum neurotoxin B light chain activity. J. Protein Chem. 22 (2003) 441-448
22. Kalb S.R., Moura H., Boyer A.E., McWilliams L.G., Pirkle J.L., and Barr J.R. The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples. Anal. Biochem. 351 (2006) 84-92
23. Pellizzari R., Mason S., Shone C.C., and Montecucco C. The interaction of synaptic vesicle-associated membrane protein/synaptobrevin with botulinum neurotoxins D and F. FEBS Lett. 409 (1997) 339-342
24. Yamasaki S., Baumeister A., Binz T., Blasi J., Link E., Cornille F., Roques B., Fykse E.M., Sudhof T.C., and Jahn R. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J. Biol. Chem. 269 (1994) 12764-12772
25. Agarwal R., Binz T., and Swaminathan S. Structural analysis of botulinum neurotoxin serotype F light chain: Implications on substrate binding and inhibitor design. Biochemistry 44 (2005) 11758-11765
26. Pellizzari R., Rossetto O., Lozzi L., Giovedi S., Johnson E., Shone C.C., and Montecucco C. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins. J. Biol. Chem. 271 (1996) 20353-20358
27. Arndt J.W., Yu W., Bi F., and Stevens R.C. Crystal structure of botulinum neurotoxin type G light chain: Serotype divergence in substrate recognition. Biochemistry 44 (2005) 9574-9580
28. Sikorra S., Henke T., Swaminathan S., Galli T., and Binz T. Identification of the amino acid residues rendering TI-VAMP insensitive toward botulinum neurotoxin B. J. Mol. Biol. 357 (2006) 574-582
29. Arndt J.W., Chai Q., Christian T., and Stevens R.C. Structure of botulinum neurotoxin type D light chain at 1.65 Å resolution: Repercussions for VAMP-2 substrate specificity. Biochemistry 45 (2006) 3255-3262
30. Fang H., Luo W., Henkel J., Barbieri J., and Green N. A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate. Proc. Natl. Acad. Sci. USA 103 (2006) 6958-6963
31. Schmidt J.J., and Bostian K.A. Endoproteinase activity of type A botulinum neurotoxin: Substrate requirements and activation by serum albumin. J. Protein Chem. 16 (1997) 19-26
32. Shone C.C., and Roberts A.K. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin. Eur. J. Biochem. 225 (1994) 263-270
33. Binz T., Blasi J., Yamasaki S., Baumeister A., Link E., Sudhof T.C., Jahn R., and Niemann H. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269 (1994) 1617-1620
34. Schmidt J.J., and Bostian K.A. Proteolysis of synthetic peptides by type A botulinum neurotoxin. J. Protein Chem. 14 (1995) 703-708
35. Cornish-Bowden A. Fundamentals of Enzyme Kinetics (1995), Portland Press, London
36. Liu Y., Kati W., Chen C.M., Tripathi R., Molla A., and Kohlbrenner W. Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction. Anal. Biochem. 267 (1999) 331-335
37. Greis K.D. Mass spectrometry for enzyme assays and inhibitor screening: An emerging application in pharmaceutical research. Mass Spectrom. Rev. 26 (2007) 324-339
38. Dong M., Tepp W.H., Johnson E.A., and Chapman E.R. Using fluorescent sensors to detect botulinum neurotoxin activity in vitro and in living cells. Proc. Natl. Acad. Sci. USA 101 (2004) 14701-14706
39. Parpura V., and Chapman E.R. Detection of botulinum toxins: Micromechanical and fluorescence-based sensors. Croat. Med. J. 46 (2005) 491-497
40. Boyer A.E., Moura H., Woolfitt A.R., Kalb S.R., McWilliams L.G., Pavlopoulos A., Schmidt J.G., Ashley D.L., and Barr J.R. From the mouse to the mass spectrometer: Detection and differentiation of the endoproteinase activities of botulinum neurotoxins A-G by mass spectrometry. Anal. Chem. 77 (2005) 3916-3924